456.16
  Price0.18%   +0.81
(After Hours: 456.60 +0.44 +0.10%)
Jun-16-21 03:17AM Tracking Al Gore's Generation Investment Management Portfolio - Q1 2021 UpdateSeeking Alpha
Jun-13-21 05:11AM 3 Biotech ETFs That Could Double Your Money by 2025 With Zero EffortThe Motley Fool
04:22AM The Stocks To Focus On TodaySeeking Alpha
Jun-12-21 06:10AM Has Illumina Lost Its Shine?The Motley Fool
Jun-11-21 09:26AM Stock Market News for Jun 11, 2021Zacks Investment Research
Jun-10-21 06:43AM The Zacks Analyst Blog Highlights: Intel, NextEra Energy, PetroChina, Illumina and BiogenZacks Investment Research
Jun-09-21 06:47AM Will Illumina Be a Trillion-Dollar Stock by 2035?The Motley Fool
Jun-07-21 03:25AM 5 Top ETFs With Exposure To BiogenBenzinga
02:59AM Biotech ETF Powering HigherInvesting.com
Jun-04-21 12:55PM This Biotech Just Made History. Will Its Stock Follow?The Motley Fool
08:37AM 2 Winners for a Drug Development Future That Looks Nothing Like the PastThe Motley Fool
Jun-03-21 03:28AM LHC Group (LHCG) Expands Hospice Presence with New BuyoutZacks Investment Research
Jun-02-21 10:27AM CEO of Newly IPO'd Seer: For Biotech Investors, Proteins Are The New DNAThe Motley Fool
08:03AM Here's Why You Should Retain Allscripts (MDRX) Stock for NowZacks Investment Research
Jun-01-21 09:08AM Here's Why You Should Retain PRA Health (PRAH) Stock for NowZacks Investment Research
08:45AM Baxter's (BAX) PrisMax 2 to Simplify Organ Support TherapiesZacks Investment Research
Jun-01-21 07:40AM Illumina (ILMN) Expands NIPT Offering With New CollaborationZacks Investment Research
May-31-21 10:45AM BD (BDX) to Boost Lab Efficacy With BD Kiestra UCA's U.S. LaunchZacks Investment Research
07:24AM Cooper Companies (COO) to Post Q2 Earnings: What's in Store?Zacks Investment Research
May-29-21 07:07AM Could Bionano Genomics Be a Millionaire-Maker Stock?The Motley Fool
06:45AM 2 Top Biotech Picks to Buy and Hold for the Next 10 YearsThe Motley Fool
May-28-21 10:09AM Bristol Myers' (BMY) Zeposia Gets FDA Nod for Ulcerative ColitisZacks Investment Research
09:31AM Change Healthcare (CHNG) Q4 Earnings & Revenues Top EstimatesZacks Investment Research
May-27-21 11:31AM Illumina (ILMN) Down 1.9% Since Last Earnings Report: Can It Rebound?Zacks Investment Research
10:35AM NextGen (NXGN) Announces Positive Telehealth Survey ResultsZacks Investment Research
May-27-21 05:53AM QIAGEN (QGEN)-Mirati Deal to Boost Companion Diagnostic ArmZacks Investment Research
May-26-21 08:51AM Allscripts (MDRX), Lash Group Team Up for Better Patient CareZacks Investment Research
07:06AM Exact Sciences (EXAS) Reveals Promising Data on CologuardZacks Investment Research
May-25-21 11:30AM Is Illumina (ILMN) Outperforming Other Medical Stocks This Year?Zacks Investment Research
10:21AM Here's Why You Should Retain Glaukos (GKOS) Stock for NowZacks Investment Research
May-25-21 09:46AM Here's Why You Should Retain Accuray (ARAY) Stock for NowZacks Investment Research
May-24-21 10:19AM Here's Why You Should Retain Merit Medical (MMSI) Stock for NowZacks Investment Research
09:36AM PerkinElmer's (PKI) COVID-19 Test Kit Part of Investigative StudyZacks Investment Research
May-22-21 06:11AM With Expenses Growing Faster Than Revenue, Is This Cathie Wood Stock in Trouble?The Motley Fool
May-21-21 08:03AM Ecolab (ECL) Launches Roach Control Device for Food OutletsZacks Investment Research
May-20-21 09:47AM Here's Why You Should Hold on to Avanos (AVNS) Stock for NowZacks Investment Research
09:19AM NextGen (NXGN) Implements API to Aid COVID-19 VaccinationZacks Investment Research
May-20-21 07:27AM The Zacks Analyst Blog Highlights: PulteGroup, Weyerhaeuser, General Motors, Illumina and Marriott InternationalZacks Investment Research
06:50AM Down More Than 20%, Is This Cathie Wood Biotech A Buy?The Motley Fool
May-19-21 08:04AM Top 5 S&P 500 Stocks at Lucrative Valuation Amid May TurmoilZacks Investment Research
07:22AM STERIS (STE) Q4 Earnings Fall Shy of Estimates, FY22 View UpZacks Investment Research
May-17-21 10:00AM National Vision (EYE) Q1 Earnings Top Estimates, View UpZacks Investment Research
07:24AM Haemonetics (HAE) Q4 Earnings Lag Estimates, Gross Margin DipsZacks Investment Research
May-15-21 10:57AM Early Tesla backer and top fund manager attacks Warren Buffett’s strategy. Here’s his investing advice.MarketWatch
May-14-21 11:48AM : Early Tesla backer and top fund manager attacks Warren Buffett’s strategy. Here’s his investing advice.MarketWatch
08:13AM : Early Tesla backer and top fund manager attacks Warren Buffett’s strategy. Here’s his investing advice.MarketWatch
May-14-21 12:05PM : Early Tesla backer and top fund manager attacks Warren Buffett’s strategy. Here’s his investing advice.MarketWatch
May-13-21 10:22AM Here's Why You Should Add Bruker (BRKR) to Your PortfolioZacks Investment Research
06:16AM 3 Cathie Wood Stocks for a $150 Billion Market That's Just FormingThe Motley Fool
May-11-21 10:59AM Cardiovascular Systems (CSII) Q3 Loss Widens, Gross Margin DipsZacks Investment Research
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers Squibb Company. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Cap:    |  Volume (24h):